Dr. Anne L. Peters is currently a professor at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs. She also directs diabetes centers in Beverly Hills and in underserved East Los Angeles and works with the LA County Department of Health Services on a county-wide diabetes program.
Dr. Peters earned her undergraduate degree from Wesleyan University located in Middletown, Connecticut and her medical degree from the Pritzker School of Medicine at the University of Chicago. She performed her internal medicine residency at Stanford University and Harbor UCLA Medical Center (final year) and a fellowship in endocrinology at Cedars-Sinai Medical Center. She was in charge of the clinical diabetes programs at Cedars and then at UCLA before moving to USC.
Dr. Peters has been a principal investigator on multiple clinical trials focusing on diabetes and diabetes prevention, and is currently a principal investigator on three NIH grants: the NIH Look AHEAD Study, the UCLA/USC NIH P50 program project, “Family and Neighborhood Interventions to Reduce Heart Disease Risk in East LA,” and the NIH Vitamin D and Type 2 Diabetes (D2d) Study. In addition, she established the Community Diabetes Initiatives Research Center (CDI) in collaboration with Children’s Hospital Los Angeles with funding from the Keck Foundation, JDRF, ADA, NIH, Rose Hills Foundation, California Nutrition Network, TrialNet, and the Helmsley Trust.
She has been an invited speaker at hundreds of local, national, and international medical conferences. Dr. Peters has authored three books on diabetes and more than 100 articles appearing in peer-reviewed medical journals including JAMA, the New England Journal of Medicine, Annals of Internal Medicine, and Diabetes Care. She serves on the ABIM Endocrine Board, multiple ADA committees, and the EASD/ADA Diabetes Technology Committee. Dr. Peters received the ADA Outstanding Physician Clinician Award in 2008 and the 2010 Bernardo Houssay Award from the National Minority Quality Forum for her work with the underserved. She is an author of the “ADA/EASD Position Statement on the Management of Hyperglycemia in Type 2 Diabetes” and the ADA Position Statement on the “Treatment of Type 1 Diabetes Across the Lifespan.”